EDIT compared with ZLAB: revenue, margins and what each company keeps, and the suppliers and customers both name

EDITEditas Medicine, Inc.

Mkt capRevenueRevenue

ZLABZai Lab Ltd

Mkt capRevenueRevenue

Compare

EDITEditas Medicine, Inc.

ZLABZai Lab Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

EDIT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±18.5%▲+5.45%×0.30

May 5 '26±19.0%▲+1.33%×0.07

Q1 FY26±16.6%▲+16.00%×0.96

Q3 FY25±11.2%▲+2.02%×0.18

ZLAB

Reportimpliedrealized× implied

Q2 FY26—▲+13.66%—

May 7 '26—▼−5.93%—

Q1 FY26

= impliedEDIT realized, solidZLAB realized, hatchedOne scale, both sides: full bar = 19%× = |realized| ÷ impliedSource: market data

—

▲+1.55%

—

Nov 6 '25—▼−6.65%—

EDITEditas Medicine, Inc.

2.65▼−9.48%· post 2.62

Mkt cap$410.1MRevenue$12MQ2 FY26Revenue—

ZLABZai Lab Ltd

22.09▼−1.21%· post 22.10

ClosedOct 30 '26

Mkt cap$2.5BRevenue$106MQ2 FY26Revenue$460MFY25

Compare

ClosedOct 30 '26

EDITEditas Medicine, Inc.

ZLABZai Lab Ltd

2.65▼−9.48%post 2.62

Price

22.09▼−1.21%post 22.10

$410.1M

Mkt cap

$2.5B

Q2 FY26$12M

Revenue

$106MQ2 FY26

—

Revenue

$460MFY25

EDIT2.65▼−9.48%vsZLAB22.09▼−1.21%ClosedOct 30 '26